Metabolic
1 drug is in development for Metabolic Diseases.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Metabolic Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Metabolic Diseases context
Metabolic·MeSH: Metabolic Diseases (D008659)
Also known as: Disease, Metabolic, Thesaurismoses, Thesaurismosis
Frequently asked questions
How many drugs are in development for Metabolic Diseases?
BioSniper tracks 1 drug in development for Metabolic Diseases across 1 company.
How many clinical trials target Metabolic Diseases?
There are 7 clinical trials targeting Metabolic Diseases tracked by BioSniper.